Design, Synthesis and Activity Evaluation of Novel Bromodomain-Containing Protein 4 (BRD4) Small Molecule Inhibitor Based on ABBV-075

doi:10.6023/cjoc202007059

Chinese Journal of Organic Chemistry ›› 2021, Vol. 41 ›› Issue (4): 1712-1721.DOI: 10.6023/cjoc202007059 Previous Articles Next Articles

ARTICLES

基于ABBV-075的新型溴结构域蛋白4 (BRD4)小分子抑制剂的设计、合成及活性评价

徐晨淏^a^,^b^,^c^,^d, 龚云鹏^a^,^b^,^c^,^d, 陈雅欣^a^,^b^,^c^,^d, 宋启梦^a^,^b^,^c^,^d, 李娇^a^,^b^,^c^,^d, 郑一超^a^,^b^,^c^,^d, 李雯^a^,^b^,^c^,^d^,^*(), 孙凯^a^,^b^,^c^,^d^,^*(), 刘宏民^a^,^b^,^c^,^d^,^*()

a 郑州大学药学院郑州 450001
b 郑州大学药物研究院郑州 450001
c 新药创制与药物安全性评价河南省协同创新中心郑州 450001
d 药物关键制备技术教育部重点实验室郑州 450001

收稿日期:2020-07-26 修回日期:2020-10-21 发布日期:2020-12-05
通讯作者: 李雯, 孙凯, 刘宏民
基金资助:
国家自然科学基金(81438005); 国家自然科学基金(81773562); 国家蛋白质重点研究项目基金(SQ2018YFE011359); 河南省重点研究项目基金(1611003110100)

Design, Synthesis and Activity Evaluation of Novel Bromodomain-Containing Protein 4 (BRD4) Small Molecule Inhibitor Based on ABBV-075

Chenhao Xu^a^,^b^,^c^,^d, Yunpeng Gong^a^,^b^,^c^,^d, Yaxin Chen^a^,^b^,^c^,^d, Qimeng Song^a^,^b^,^c^,^d, Jiao Li^a^,^b^,^c^,^d, Yichao Zheng^a^,^b^,^c^,^d, Wen Li^a^,^b^,^c^,^d^,^*(), Kai Sun^a^,^b^,^c^,^d^,^*(), Hongmin Liu^a^,^b^,^c^,^d^,^*()

a School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001
b Institute of Drug Discovery & Development, Zhengzhou University, Zhengzhou 450001
c Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, Zhengzhou 450001
d Key Laboratory of Technology of Drug Preparation, Ministry of Education, Zhengzhou 450001

Received:2020-07-26 Revised:2020-10-21 Published:2020-12-05
Contact: Wen Li, Kai Sun, Hongmin Liu
About author:
* Corresponding authors. E-mail: liwen@zzu.edu.cn;
E-mail: kaisun@zzu.edu.cn;
E-mail: liuhm@zzu.edu.cn
Supported by:
National Natural Science Foundation of China(81438005); National Natural Science Foundation of China(81773562); National Key Research Program of Proteins(SQ2018YFE011359); Key Research Program of Henan Province(1611003110100)

1. cjoc202007059辅助材料.pdf(1068KB)

Abstract

In order to discover novel bromodomain-containing protein 4 (BRD4) small molecule inhibitor, 16 compounds with 4 different nuclei based on ABBV-075 were designed and synthesized through scaffold hopping. The conditions of the Suzuki coupling reaction in the synthesis steps were optimized and the activity of all compounds against BRD4 was tested. The results indicated that compound N-(4-(2,4-difluorophenoxy)-3-(4-oxo-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidin-2-yl)- phenyl)ethanesulfonamide (15o) had 51% at concentration of 10 μmol/L with IC ₅₀ value of (16.39±1.20) μmol/L, possessing obvious BRD4 inhibitory activity. The molecular docking results showed that15oformed key hydrogen bonds with Asn433 and Asp381. The picture of superposed conformation of 15o and homolog of ABBV-075 exhibited the combination difference between them, explaining the reason of activity gap, which would provide excellent ideas for further study.

Key words: BRD4 inhibitor, ABBV-075, synthesis and optimization, bioactivity, molecular docking

Cite this article

Chenhao Xu, Yunpeng Gong, Yaxin Chen, Qimeng Song, Jiao Li, Yichao Zheng, Wen Li, Kai Sun, Hongmin Liu. Design, Synthesis and Activity Evaluation of Novel Bromodomain-Containing Protein 4 (BRD4) Small Molecule Inhibitor Based on ABBV-075[J]. Chinese Journal of Organic Chemistry, 2021, 41(4): 1712-1721.

Export EndNote|Reference Manager|ProCite|BibTeX|RefWorks

share this article

Fig. & Tab. 13

References 26

[1]	Smith, S.G.; Zhou, M.-M. ACS Chem. Biol. 2016, 11,598.
[2]	Filippakopoulos, P.; Picaud, S.; Mangos, M.; Keates, T.; Lambert, J.-P.; Barsyte-Lovejoy, D.; Felletar, I.; Volkmer, R.; Müller, S.; Pawson, T.; Gingras, A.-C.; Arrowsmith, C.H.; Knapp, S. Cell 2012, 149,214. pmid: 22464331
[3]	Lee, J.-E.; Park, Y.-K.; Park, S.; Jang, Y.; Waring, N.; Dey, A.; Ozato, K.; Lai, B.; Peng, W.; Ge, K. Nat. Commun. 2017, 8,2217. pmid: 29263365
[4]	Muller, S.; Filippakopoulos, P.; Knapp, S. Expert. Rev. Mol.Med. 2011, 13,e29.
[5]	Qin, Z.-Y.; Wang, T.; Su, S.; Shen, L.-T.; Zhu, G.-X.; Liu, Q.; Zhang, L.; Liu, K.-W.; Zhang, Y.; Zhou, Z.-H.; Zhang, X.-N.; Wen, L.-Z.; Yao, Y.-L.; Sun, W.-J.; Guo, Y.; Liu, K.-J.; Liu, L.; Wang, X.-W.; Wei, Y.-L.; Wang, J.; Xiao, H.-L.; Liu, P.; Bian, X.-W.; Chen, D.-F.; Wang, B. Cancer Res. 2019, 79,4869. pmid: 31311807
[6]	Wang, Q.; Sun, Y.; Li, T.; Liu, L.; Zhao, Y.; Li, L.; Zhang, L.; Meng, Y. Mol. Med. Rep. 2019, 19,499.
[7]	Ghosh, S.; Lora, J.M. Drug Discovery Today: Technol. 2016, 19,39.
[8]	Hargreaves, D.C.; Horng, T.; Medzhitov, R. Cell 2009, 138,129. pmid: 19596240
[9]	Liu, Z.; Wang, P.; Chen, H.; Wold, E.A.; Tian, B.; Brasier, A.R.; Zhou, J. J. Med. Chem. 2017, 60,4533. pmid: 28195723
[10]	Duan, Y.; Guan, Y.; Qin, W.; Zhai, X.; Yu, B.I. N.; Liu, H. MedChemComm 2019,10.
[11]	Filippakopoulos, P.; Qi, J.; Picaud, S.; Shen, Y.; Smith, W.B.; Fedorov, O.; Morse, E.M.; Keates, T.; Hickman, T.T.; Felletar, I.; Philpott, M.; Munro, S.; McKeown, M.R.; Wang, Y.; Christie, A.L.; West, N.; Cameron, M.J.; Schwartz, B.; Heightman, T.D.; La Thangue, N.; French, C.A.; Wiest, O.; Kung, A.L.; Knapp, S.; Bradner, J.E. Nature 2010, 468,1067. doi: 10.1038/nature09504 pmid: 20871596
[12]	Dawson, M.A.; Prinjha, R.K.; Dittmann, A.; Giotopoulos, G.; Bantscheff, M.; Chan, W.-I.; Robson, S.C.; Chung, C.-w.; Hopf, C.; Savitski, M.M.; Huthmacher, C.; Gudgin, E.; Lugo, D.; Beinke, S.; Chapman, T.D.; Roberts, E.J.; Soden, P.E.; Auger, K.R.; Mirguet, O.; Doehner, K.; Delwel, R.; Burnett, A.K.; Jeffrey, P.; Drewes, G.; Lee, K.; Huntly, B.J. P.; Kouzarides, T. Nature 2011, 478,529.
[13]	Knapp, S.; Arruda, P.; Blagg, J.; Burley, S.; Drewry, D.H.; Edwards, A.; Fabbro, D.; Gillespie, P.; Gray, N.S.; Kuster, B.; Lackey, K.E.; Mazzafera, P.; Tomkinson, N.C. O.; Willson, T.M.; Workman, P.; Zuercher, W.J. Nat. Chem. Biol. 2013, 9,3.
[14]	Ember, S.W. J.; Zhu, J.-Y.; Olesen, S.H.; Martin, M.P.; Becker, A.; Berndt, N.; Georg, G.I.; Schönbrunn, E. ACS Chem. Biol. 2014, 9,1160.
[15]	Liu, S.; Yosief, H.O.; Dai, L.; Huang, H.; Dhawan, G.; Zhang, X.; Muthengi, A.M.; Roberts, J.; Buckley, D.L.; Perry, J.A.; Wu, L.; Bradner, J.E.; Qi, J.; Zhang, W. J. Med. Chem. 2018, 61,7785. pmid: 30125504
[16]	McDaniel, K.F.; Wang, L.; Soltwedel, T.; Fidanze, S.D.; Hasvold, L.A.; Liu, D.; Mantei, R.A.; Pratt, J.K.; Sheppard, G.S.; Bui, M.H.; Faivre, E.J.; Huang, X.; Li, L.; Lin, X.; Wang, R.; Warder, S.E.; Wilcox, D.; Albert, D.H.; Magoc, T.J.; Rajaraman, G.; Park, C.H.; Hutchins, C.W.; Shen, J.J.; Edalji, R.P.; Sun, C.C.; Martin, R.; Gao, W.; Wong, S.; Fang, G.; Elmore, S.W.; Shen, Y.; Kati, W.M. J. Med. Chem. 2017, 60,8369.
[17]	Faivre, E.J.; Wilcox, D.; Lin, X.; Hessler, P.; Torrent, M.; He, W.; Uziel, T.; Albert, D.H.; McDaniel, K.; Kati, W.; Shen, Y. Mol. Cancer Res. 2017, 15,35. pmid: 27707886
[18]	Li, Z.; Xiao, S.; Yang, Y.; Chen, C.; Lu, T.; Chen, Z.; Jiang, H.; Chen, S.; Luo, C.; Zhou, B. J. Med. Chem. 2020, 63,3956. pmid: 32208600
[19]	Sheppard, G.S.; Wang, L.; Fidanze, S.D.; Hasvold, L.A.; Liu, D.; Pratt, J.K.; Park, C.H.; Longenecker, K.; Qiu, W.; Torrent, M.; Kovar, P.J.; Bui, M.; Faivre, E.; Huang, X.; Lin, X.; Wilcox, D.; Zhang, L.; Shen, Y.; Albert, D.H.; Magoc, T.J.; Rajaraman, G.; Kati, W.M.; McDaniel, K.F. J. Med. Chem. 2020, 63,5585. pmid: 32324999
[20]	Brown, N. Mol. Inf. 2014, 33,458.
[21]	Li, Z.-H.; Yang, D.-X.; Geng, P.-F.; Zhang, J.; Wei, H.-M.; Hu, B.; Guo, Q.; Zhang, X.-H.; Guo, W.-G.; Zhao, B.; Yu, B.; Ma, L.-Y.; Liu, H.-M. Eur. J. Med. Chem. 2016, 124,967.
[22]	Xie, H.; Zeng, L.; Zeng, S.; Lu, X.; Zhang, G.; Zhao, X.; Cheng, N.; Tu, Z.; Li, Z.; Xu, H.; Yang, L.; Zhang, X.; Huang, M.; Zhao, J.; Hu, W. Eur. J. Med. Chem. 2012, 52,205. pmid: 22475866
[23]	Miyaura, N.; Suzuki, A. Chem. Rev. 1995, 95,2457.
[24]	Ramgren, S.D.; Hie, L.; Ye, Y.; Garg, N.K. Org. Lett. 2013, 15,3950.
[25]	Hu, Y.-H. WO 2018086585, 2018.
[26]	Hu, Y.-H. WO 2018086604, 2018.

Entry	Catalyst	Ligand	Base	Solvent	T/℃	Time/h	Yield^a/%
1	Pd₂(dba)₃	X-Phos	Cs₂CO₃	1,4-Dioxane/H₂O (V∶V=4∶1)	90	6	0
2	Pd₂(dba)₃	X-Phos	Cs₂CO₃	DMSO	90	6	0
3	Pd₂(dba)₃	X-Phos	Cs₂CO₃	DMF	90	6	0
4	Pd₂(dba)₃	X-Phos	K₃PO₄	1,4-Dioxane/H₂O (V∶V=4∶1)	90	6	0
5	Pd₂(dba)₃	X-Phos	Na₂CO₃	1,4-Dioxane/H₂O (V∶V=4∶1)	90	6	0
6	Pd₂(dba)₃	PPh₃	Cs₂CO₃	1,4-Dioxane/H₂O (V∶V=4∶1)	90	6	0
7	Pd(OAc)₂	X-Phos	Cs₂CO₃	1,4-Dioxane/H₂O (V∶V=4∶1)	90	6	0
8	Pd(OAc)₂	PPh₃	Cs₂CO₃	1,4-Dioxane/H₂O (V∶V=4∶1)	90	6	0
9	Pd(dppf)Cl₂	None	Cs₂CO₃	1,4-Dioxane/H₂O (V∶V=4∶1)	90	6	0
10	(dtbpf)PdCl₂	None	Cs₂CO₃	1,4-Dioxane/H₂O (V∶V=4∶1)	90	6	30
11	(dtbpf)PdCl₂	None	K₃PO₄	1,4-Dioxane/H₂O (V∶V=4∶1)	90	6	12
12	(dtbpf)PdCl₂	None	Na₂CO₃	1,4-Dioxane/H₂O (V∶V=4∶1)	90	6	10
13	(dtbpf)PdCl₂	None	Cs₂CO₃	1,4-Dioxane/H₂O (V∶V=4∶1)	90	12	40
14	(dtbpf)PdCl₂	None	Cs₂CO₃	1,4-Dioxane/H₂O (V∶V=4∶1)	90	24	40
15	(dtbpf)PdCl₂	None	Cs₂CO₃	1,4-Dioxane	90	12	0
16	(dtbpf)PdCl₂	None	Cs₂CO₃	DMSO	90	12	0
17	(dtbpf)PdCl₂	None	Cs₂CO₃	1,4-Dioxane/H₂O (V∶V=4∶1)	30	12	0
18	(dtbpf)PdCl₂	None	Cs₂CO₃	1,4-Dioxane/H₂O (V∶V=4∶1)	60	12	0

Entry	Catalyst	Ligand	Base	Solvent	T/℃	Time/h	Yield^a/%
1	Pd₂(dba)₃	X-Phos	Cs₂CO₃	1,4-Dioxane/H₂O (V∶V=4∶1)	90	6	0
2	Pd₂(dba)₃	X-Phos	Cs₂CO₃	DMSO	90	6	0
3	Pd₂(dba)₃	X-Phos	Cs₂CO₃	DMF	90	6	0
4	Pd₂(dba)₃	X-Phos	K₃PO₄	1,4-Dioxane/H₂O (V∶V=4∶1)	90	6	0
5	Pd₂(dba)₃	X-Phos	Na₂CO₃	1,4-Dioxane/H₂O (V∶V=4∶1)	90	6	0
6	Pd₂(dba)₃	PPh₃	Cs₂CO₃	1,4-Dioxane/H₂O (V∶V=4∶1)	90	6	0
7	Pd(OAc)₂	X-Phos	Cs₂CO₃	1,4-Dioxane/H₂O (V∶V=4∶1)	90	6	0
8	Pd(OAc)₂	PPh₃	Cs₂CO₃	1,4-Dioxane/H₂O (V∶V=4∶1)	90	6	0
9	Pd(dppf)Cl₂	None	Cs₂CO₃	1,4-Dioxane/H₂O (V∶V=4∶1)	90	6	0
10	(dtbpf)PdCl₂	None	Cs₂CO₃	1,4-Dioxane/H₂O (V∶V=4∶1)	90	6	30
11	(dtbpf)PdCl₂	None	K₃PO₄	1,4-Dioxane/H₂O (V∶V=4∶1)	90	6	12
12	(dtbpf)PdCl₂	None	Na₂CO₃	1,4-Dioxane/H₂O (V∶V=4∶1)	90	6	10
13	(dtbpf)PdCl₂	None	Cs₂CO₃	1,4-Dioxane/H₂O (V∶V=4∶1)	90	12	40
14	(dtbpf)PdCl₂	None	Cs₂CO₃	1,4-Dioxane/H₂O (V∶V=4∶1)	90	24	40
15	(dtbpf)PdCl₂	None	Cs₂CO₃	1,4-Dioxane	90	12	0
16	(dtbpf)PdCl₂	None	Cs₂CO₃	DMSO	90	12	0
17	(dtbpf)PdCl₂	None	Cs₂CO₃	1,4-Dioxane/H₂O (V∶V=4∶1)	30	12	0
18	(dtbpf)PdCl₂	None	Cs₂CO₃	1,4-Dioxane/H₂O (V∶V=4∶1)	60	12	0

Compd.	R¹	Inhibition/% at 10 μmol/L	IC₅₀^a/(μmol?L^–1)
15a	H	23	—
15b	2,4-F₂	5	—
15c	3-CH₃	20	—
15d	4-CH₃	3	—
15e	3-OCH₃	5	–
15f	4-F	20	–
(+)-JQ1			0.070±0.001

Compd.	R¹	Inhibition/% at 10 μmol/L	IC₅₀^a/(μmol?L^–1)
15a	H	23	—
15b	2,4-F₂	5	—
15c	3-CH₃	20	—
15d	4-CH₃	3	—
15e	3-OCH₃	5	–
15f	4-F	20	–
(+)-JQ1			0.070±0.001

Compd.	R¹	Inhibition/% at 10 μmol/L	IC₅₀^a/ (μmol?L^–1)	Compd.	R¹	Inhibition/% at 10 μmol/L	IC₅₀^a/ (μmol?L^–1)
15g	H	12	–	15m	H	5	—
15h	3-F	13	–	15n	2,4-F₂	35	—
15i	4-F	25	—	15o	2,4-F₂	51	16.39±1.20
15j	4-CN	5	—	15p	2,4-F₂	24	—
15k	H	28	—	(+)-JQ1			0.070±0.001
15l	H	31	—

基于ABBV-075的新型溴结构域蛋白4 (BRD4)小分子抑制剂的设计、合成及活性评价

Design, Synthesis and Activity Evaluation of Novel Bromodomain-Containing Protein 4 (BRD4) Small Molecule Inhibitor Based on ABBV-075

RichHTML

PDF

Supporting Info.

Knowledge

Abstract

Cite this article

share this article

Fig. & Tab. 13

References 26

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Simin Wu, Jiaxin Tang, Yujia Zhou, Xuetao Xu, Haoxing Zhang, Shaohua Wang. α-Glucosidase Inhibition Research of Derivatives Based on 2β-Acetoxyferruginol Scaffold Excluding Acetic Acid Group [J]. Chinese Journal of Organic Chemistry, 2024, 44(2): 613-621.
[2]	Feng Wang, Yu Chen, Hongyan Pei, Jing Zhang, Lixin Zhang. Design, Synthesis and Antifungal Activities of Novel 1,2,4-Oxadiazole Derivatives Containing Piperidine [J]. Chinese Journal of Organic Chemistry, 2023, 43(8): 2826-2836.
[3]	Min Liu, Dongyan Yang, Yumei Xiao, Wangcang Su, Fenghai Zhao, Qin Zhaohai .. Synthesis and Bioactivities of 5-Nitroimino-[1,4-2H]-1,2,4-triazolines as Olefin-Imidacloprid Mimics [J]. Chinese Journal of Organic Chemistry, 2023, 43(8): 2790-2799.
[4]	Jinyan He, Fuyun Tian, Qingqing Wu, Yueming Zheng, Yuting Chen, Haiyan Xu, Zhengsheng Jin, Li Zhan, Xinqiang Cheng, Yueling Gu, Zhaobing Gao, Guilong Zhao. Design, Synthesis and Bioactivity of [3.3.3]Propellane-Based Voltage-Gated Calcium Channel α2δ Subunit Ligands [J]. Chinese Journal of Organic Chemistry, 2023, 43(6): 2226-2238.
[5]	Yang Sun, Yang Wang, Zichan Zhang, Ye Qian, Guicheng Luo, Beibei Zhou, Lisha Miao, Yudie Chen, Hong Dai, Baolin Xu, Zhengguang Wu. Synthesis and Bioactivities of Novel Pyrazole Oxime Derivatives Containing 1,3,4-Oxadiazole Group [J]. Chinese Journal of Organic Chemistry, 2023, 43(4): 1584-1590.
[6]	Huan Xu, Hongfei Wu, Xiaoming Zhang, Xingxing Lu, Tengda Sun, Yue Qi, Yufan Lin, Xinling Yang, Li Zhang, Yun Ling. Design, Synthesis and Bioactivity of Sulfonyl Hydrazides and Hydrazides Containing Fragment 1,2,3,4-Tetrahydroisoquinoline [J]. Chinese Journal of Organic Chemistry, 2023, 43(2): 725-733.
[7]	Changxing Sun, Fuhao Zhang, Huan Zhang, Penghui Li, Lin Jiang. Design, Synthesis, Fungicidal Activity and Molecular Docking Study of Novel 2-(1-Methyl-1H-pyrazol-4-yl)pyrimidine-4-carboxamides [J]. Chinese Journal of Organic Chemistry, 2023, 43(1): 229-235.
[8]	Changkai Wang, Tengda Sun, Xuebo Zhang, Xinling Yang, Xingxing Lu, Huan Xu, Fasheng Shi, Li Zhang, Yun Ling. Design, Synthesis and Bioactivity of Novel Fluoropyrazole Hydrazides [J]. Chinese Journal of Organic Chemistry, 2022, 42(5): 1527-1536.
[9]	Xiu Wang, Wengui Duan, Guishan Lin, Baoyu Li, Wenjing Zhang, Fuhou Lei. Synthesis, Antifungal Activity, Three-Dimensional Quantitative Structure-Activity Relationship and Molecular Docking Study of 4-Acyl-3-amino-1,2,4-triazole-thioether Derivatives Containing Natural Pinene Structure [J]. Chinese Journal of Organic Chemistry, 2022, 42(3): 871-883.
[10]	Yuanfang Kong, Bin Yang, Yan Zhuang, Jingyu Zhang, Demei Sun, Chunhong Dong. Research Progress on the Synthesis and Structure-Activity Relationship of Five Hypoglycemic Active Heterocycles Based on Dipeptidyl Peptidase 4 (DPP-4) Target Design [J]. Chinese Journal of Organic Chemistry, 2022, 42(3): 770-784.
[11]	Yucheng Cui, Meihua Chen, Guishan Lin, Wengui Duan, Qingmin Li, Renxuan Zou, Bo Cen. Synthesis, Antifungal Activity and Molecular Docking Study of 1,3,4-Thiadiazole-Urea Compounds Containing gem-Dimethylcyclopropane Ring Structure [J]. Chinese Journal of Organic Chemistry, 2022, 42(11): 3784-3797.
[12]	Jiyan Shao, Zhijie Li, Yajun Wang, Yuyan Xiong, Xiangdong Hu. Synthesis and Bioactivity of Tropone Derivatives as Potential Compounds against Human Gastric Cancer Cells Growth [J]. Chinese Journal of Organic Chemistry, 2021, 41(9): 3675-3681.
[13]	Yingjun Li, Ledi Lin, Jihong Liu, Lixin Gao, Li Sheng, Kun Jin, Xuejie Liu, Hongjing Yang, Jia Li. Synthesis and Protein Tyrosine Phosphatase 1B (PTP1B) Inhibitory Activity Evaluation of Novel N-Acylhydrazone Derivatives Containing Carbazole and Aromatic Ring/Aromatic Fused Heterocycle [J]. Chinese Journal of Organic Chemistry, 2021, 41(9): 3593-3607.
[14]	Sha Zhou, Mukuo Wang, Weibin Xie, Shaa Zhou, Lixia Xiong, Yu Zhao, Zhengming Li. Synthesis and Insecticidal Activities of Novel Optically Active Dicarboxamides Containing N-Trifluoroacetyl Sulfulimiyl Substituents [J]. Chinese Journal of Organic Chemistry, 2021, 41(9): 3532-3538.
[15]	Yingjun Li, Ledi Lin, Kun Jin, Lixin Gao, Li Sheng, Jihong Liu, Jia Li. Synthesis and Protein Tyrosine Phosphatase 1B (PTP1B) Inhibitory Activity Evaluation of Novel Arylaminoacetylhydrazone Derivatives Containing Carbazole Moiety [J]. Chinese Journal of Organic Chemistry, 2021, 41(8): 3157-3170.